Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir plus Tenofovir in Chronic Hepatitis B with Prior Nucleos(t)ide Treatment Failure
2009-015705-40Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of entecavir and tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Primary endpoint: Primary virological response at Week 48. Started Dec 2009; status: completed.
02
Drugs
entecavirtenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2009-015705-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015705-40.